0001209191-20-035172.txt : 20200608
0001209191-20-035172.hdr.sgml : 20200608
20200608210720
ACCESSION NUMBER: 0001209191-20-035172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200604
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McLoughlin Dennis
CENTRAL INDEX KEY: 0001752004
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35060
FILM NUMBER: 20950727
MAIL ADDRESS:
STREET 1: C/O PACIRA PHARMACEUTICALS, INC.
STREET 2: 5 SYLVAN WAY, SUITE 300
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pacira BioSciences, Inc.
CENTRAL INDEX KEY: 0001396814
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510619477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 SYLVAN WAY
STREET 2: SUITE 300
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-254-3560
MAIL ADDRESS:
STREET 1: 5 SYLVAN WAY
STREET 2: SUITE 300
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Pacira Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20101029
FORMER COMPANY:
FORMER CONFORMED NAME: PACIRA INC
DATE OF NAME CHANGE: 20080318
FORMER COMPANY:
FORMER CONFORMED NAME: Blue Acquisition Corp
DATE OF NAME CHANGE: 20070418
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-04
0
0001396814
Pacira BioSciences, Inc.
PCRX
0001752004
McLoughlin Dennis
C/O PACIRA BIOSCIENCES, INC.
5 SYLVAN WAY, SUITE 300
PARSIPPANY
NJ
07054
0
1
0
0
Chief Commercial Officer
Common Stock
2020-06-04
4
S
0
1447
46.331
D
14898
D
Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
Includes 229 shares of common stock acquired under the issuer's employee stock purchase plan in December 2019.
/s/ Kristen Williams, Attorney-in-Fact
2020-06-08